DR. OSSIEUR DIEDERIK, FYSISCHE GENEESKUNDE
0841.907.936 · rovalta.com · 28/09/2026
DR. OSSIEUR DIEDERIK, FYSISCHE GENEESKUNDE
Company — Normal situation.
Financial year 2024 · Closed on 30/09/2024
Overview
Identity
Source · BCE/KBODR. OSSIEUR DIEDERIK, FYSISCHE GENEESKUNDE is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0841.907.936
- Legal form
- Private limited company
- Contributed capital
- 12 400,00 €
- Latest accounts
- 30/09/2024
Joint committees (1)
- 330
Financials
Source · NBB, 12 filingsTrend over 11 financial years
| 2024 | 2023 | 2022 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 21,6 k € | -45.1% | 39,3 k € | +15.1% | 34,2 k € | -11.7% | 38,7 k € | -68.1% | 121,5 k € |
| EBITDA | 14,6 k € | -53.0% | 31,1 k € | +17.0% | 26,6 k € | -13.3% | 30,6 k € | -73.2% | 114,3 k € |
| Operating result | 13 k € | -55.9% | 29,5 k € | +18.1% | 25 k € | -10.7% | 27,9 k € | -72.7% | 102,4 k € |
| Net result | 3,2 k € | -79.9% | 15,9 k € | -1.8% | 16,2 k € | -15.9% | 19,2 k € | -68.3% | 60,6 k € |
| Balance sheet | |||||||||
| Equity | 514,6 k € | +0.3% | 513,1 k € | +2.9% | 498,9 k € | +5.7% | 471,9 k € | +4.1% | 453,5 k € |
| Total assets | 646,2 k € | -3.4% | 668,8 k € | +3.7% | 644,6 k € | +5.0% | 613,9 k € | +3.1% | 595,6 k € |
| Cash | 18,3 k € | -61.9% | 48,2 k € | +74.5% | 27,6 k € | +323% | 6,5 k € | -76.5% | 27,8 k € |
| Debts | 129,5 k € | -15.8% | 153,9 k € | +6.7% | 144,2 k € | +4.9% | 137,5 k € | +0.3% | 137,1 k € |
Board of directors
Source · NBB, accounts to 30/09/20211 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Diederik Ossieur | Director13/12/2021 → 13/12/2031Managerended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Diederik Dr. Ossieur | DirectorManager |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 | 01/10/2018 |
| Closing of the financial year | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 | 30/09/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 25/04/2025 | 23/04/2024 | 28/04/2023 | 28/03/2022 | 21/04/2021 | 03/04/2020 |
| General meeting | 29/03/2025 | 30/03/2024 | 31/03/2023 | 26/03/2022 | 27/03/2021 | 28/03/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2024 | 29/03/2025 | 25/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 30/03/2024 | 23/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 31/03/2023 | 28/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 26/03/2022 | 28/03/2022 | Dutch | |
| Micro model | 30/09/2020 | 27/03/2021 | 21/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 28/03/2020 | 03/04/2020 | Dutch | |
| Micro model | 30/09/2018 | 30/03/2019 | 12/04/2019 | Dutch | |
| Micro model | 30/09/2017 | 31/03/2018 | 04/04/2018 | Dutch | |
| Abridged model | 30/09/2016 | 31/03/2017 | 27/04/2017 | Dutch | |
| Abridged model | 30/09/2015 | 26/03/2016 | 30/03/2016 | Dutch | |
| Abridged model | 30/09/2013 | 29/03/2014 | 25/04/2014 | Dutch | |
| Abridged model | 30/09/2012 | 30/03/2013 | 26/04/2013 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20211 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Diederik Ossieur | Director13/12/2021 → 13/12/2031Managerended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Diederik Dr. Ossieur | DirectorManager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Plein 113, 9970 Kaprijke | accounts 2022 → 2024 | Accounts 2024 · 2025-00075771 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR. OSSIEUR DIEDERIK, FYSISCHE GENEESKUNDE | accounts 2022 → 2024 | Accounts 2024 · 2025-00075771 |
Events
- 2024Annual accounts 20243,2 k €↓
- 2023Annual accounts 202315,9 k €↓
- 2022Annual accounts 202216,2 k €↓
- 2020Annual accounts 202019,2 k €↓
- 2019Annual accounts 201960,6 k €↓
- 2018Annual accounts 201897,6 k €↓
- 2017Annual accounts 201797,8 k €↑
- 2016Annual accounts 201652,8 k €↓
- 2015Annual accounts 201593,8 k €↓
- 2013Annual accounts 2013111,2 k €↑
- 2012Annual accounts 201284,9 k €